Yen-Hsiang Chang ESA-SRB-AOTA 2019

Abstracts this author is presenting:

• Lenvatinib for radioiodine refractory thyroid cancer: real-world experience in southern Taiwan — AOTA Orals V: Thyroid Cancer Treatment